Group One Trading
TRIL

Group One Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Group One Trading’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-331,989
Closed -$5.83M – 9204
2021
Q3 		$5.83M Buy
331,989
+284,618
+601% +$3.33M 0.01% 1543
2021
Q2 		$460K Sell
47,371
-21,579
-31% -$203K ﹤0.01% 4307
2021
Q1 		$741K Sell
68,950
-41,974
-38% -$519K ﹤0.01% 3579
2020
Q4 		$1.63M Buy
110,924
+58,791
+113% +$848K ﹤0.01% 2218
2020
Q3 		$741K Buy
52,133
+8,990
+21% +$89.6K ﹤0.01% 2480
2020
Q2 		$349K Buy
+43,143
New +$267K ﹤0.01% 2916
2019
Q1 		– Sell
-100
Closed – – 5594
2018
Q4 		$0 Sell
100
-2,000
-95% -$6K ﹤0.01% 5650
2018
Q3 		$12K Buy
2,100
+100
+5% +$564 ﹤0.01% 4607
2018
Q2 		$12K Hold
2,000
– – ﹤0.01% 4564
2018
Q1 		$14K Buy
+2,000
New +$15.2K ﹤0.01% 4217

Other funds holding TRIL

Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Group One Trading's TRIL Position: Q4 2021 in Review

Group One Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 331,989 shares — an estimated $5.83M sold.

Group One Trading first reported a position in TRIL in Q1 2018 and held it in 10 quarters. The position peaked at $5.83M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • Group One Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • Group One Trading sold 331,989 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $5.83M.
  • Group One Trading first reported a position in Trillium Therapeutics Inc. in Q1 2018 and held it in 10 quarters.
  • Group One Trading's Trillium Therapeutics Inc. position peaked at $5.83M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.